174 related articles for article (PubMed ID: 35652077)
21. [Scoring of disease activity using BASDAI and ASDAS method in ankylosing spondylitis].
Bobek D; Zagar I; Kovač-Durmiš K; Perić P; Ćurković B; Babić-Naglić Ð
Reumatizam; 2012; 59(1):5-10. PubMed ID: 25486721
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study).
Sellas I Fernandez A; Juanola Roura X; Alonso Ruiz A; Rosas J; Medina Luezas J; Collantes Estevez E; Abad Hernández MÁ; Carrasco Benitez V; Fisac C
Rheumatol Int; 2017 Nov; 37(11):1817-1823. PubMed ID: 28918450
[TBL] [Abstract][Full Text] [Related]
23. Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis.
Kılıç G; Kılıç E; Nas K; Karkucak M; Çapkın E; Dağlı AZ; Çevik R; Özgöçmen S
Clin Rheumatol; 2015 Mar; 34(3):515-21. PubMed ID: 24985042
[TBL] [Abstract][Full Text] [Related]
24. Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
Georgiadis S; Ørnbjerg LM; Michelsen B; Kvien TK; Di Giuseppe D; Wallman JK; Závada J; Provan SA; Kristianslund EK; Rodrigues AM; Santos MJ; Rotar Ž; Pirkmajer KP; Nordström D; Macfarlane GJ; Jones GT; van der Horst-Bruinsma I; Hellamand P; Østergaard M; Hetland ML
J Rheumatol; 2024 Jul; 51(7):673-677. PubMed ID: 38621792
[TBL] [Abstract][Full Text] [Related]
25. Bath Ankylosing Spondylitis Disease Activity Index is Associated With the Quality of Sleep in Ankylosing Spondylitis Patients.
Song BW; Jeong HJ; Kim BY; Cho YW; Son CN; Kim SS; Kim SH
J Rheum Dis; 2021 Jul; 28(3):143-149. PubMed ID: 37475993
[TBL] [Abstract][Full Text] [Related]
26. [The value of ankylosing spondylitis disease activity score in evaluating disease activity of ankylosing spondylitis].
DU XN; Li Y; Zhang SL; Zhu J; Huang F
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):206-9. PubMed ID: 22781894
[TBL] [Abstract][Full Text] [Related]
27. A patient-reported outcome measures-based composite index (RAPID3) for the assessment of disease activity in ankylosing spondylitis.
Cinar M; Yilmaz S; Cinar FI; Koca SS; Erdem H; Pay S; Dinc A; Yazici Y; Simsek I
Rheumatol Int; 2015 Sep; 35(9):1575-80. PubMed ID: 25794571
[TBL] [Abstract][Full Text] [Related]
28. Early Improvements in Disease Activity Indices Predict Long-Term Clinical Remission Suggested by the Treat-to-Target Strategy in Patients with Ankylosing Spondylitis Receiving TNF-α Inhibitor Treatment.
Nam EJ; Lee WK
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575390
[TBL] [Abstract][Full Text] [Related]
29. Use of Quantitative Vertebral Bone Marrow Fat Fraction to Assess Disease Activity and Chronicity in Patients with Ankylosing Spondylitis.
Ahn GY; Koo BS; Joo KB; Kim TH; Lee S
Korean J Radiol; 2021 Oct; 22(10):1671-1679. PubMed ID: 34402239
[TBL] [Abstract][Full Text] [Related]
30. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
Ramiro S; van der Heijde D; van Tubergen A; Stolwijk C; Dougados M; van den Bosch F; Landewé R
Ann Rheum Dis; 2014 Aug; 73(8):1455-61. PubMed ID: 24812292
[TBL] [Abstract][Full Text] [Related]
31. Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative.
Gossec L; Portier A; Landewé R; Etcheto A; Navarro-Compán V; Kroon F; van der Heijde D; Dougados M
Ann Rheum Dis; 2016 Jun; 75(6):991-6. PubMed ID: 26847821
[TBL] [Abstract][Full Text] [Related]
32. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L;
Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245
[TBL] [Abstract][Full Text] [Related]
33. Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria.
Fagerli KM; Lie E; van der Heijde D; Heiberg MS; Kaufmann C; Rødevand E; Mikkelsen K; Kalstad S; Kvien TK
Rheumatology (Oxford); 2012 Aug; 51(8):1479-83. PubMed ID: 22499062
[TBL] [Abstract][Full Text] [Related]
34. How to calculate the ASDAS based on C-reactive protein without individual questions from the BASDAI: the BASDAI-based ASDAS formula.
Aranda-Valera IC; Garrido-Castro JL; Ladehesa-Pineda L; Vazquez-Mellado J; Zarco P; Juanola X; Gonzalez-Navas C; Font-Ugalde P; Castro-Villegas MC
Rheumatology (Oxford); 2020 Jul; 59(7):1545-1549. PubMed ID: 31628804
[TBL] [Abstract][Full Text] [Related]
35. Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS).
Solmaz D; Yildirim T; Avci O; Tomas N; Akar S
Clin Rheumatol; 2016 Jul; 35(7):1753-8. PubMed ID: 26670454
[TBL] [Abstract][Full Text] [Related]
36. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity.
Salaffi F; De Angelis R; Carotti M; Gutierrez M; Sarzi-Puttini P; Atzeni F
Rheumatol Int; 2014 Aug; 34(8):1103-10. PubMed ID: 24509896
[TBL] [Abstract][Full Text] [Related]
37. Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI.
Marona J; Sepriano A; Rodrigues-Manica S; Pimentel-Santos F; Mourão AF; Gouveia N; Branco JC; Santos H; Vieira-Sousa E; Vinagre F; Tavares-Costa J; Rovisco J; Bernardes M; Madeira N; Cruz-Machado R; Roque R; Silva JL; Marques ML; Ferreira RM; Ramiro S
RMD Open; 2020 Jan; 6(1):. PubMed ID: 32144137
[TBL] [Abstract][Full Text] [Related]
38. Validation of disease activity and functional status questionnaires in spondyloarthritis.
Quinzanos I; Luong PT; Bobba S; Steuart Richards J; Majithia V; Davis LA; Caplan L
Clin Exp Rheumatol; 2015; 33(2):146-52. PubMed ID: 25664820
[TBL] [Abstract][Full Text] [Related]
39. Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis.
Castrejón I; Pincus T; Wendling D; Dougados M
RMD Open; 2016; 2(2):e000235. PubMed ID: 27486525
[TBL] [Abstract][Full Text] [Related]
40. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
Pedersen SJ; Sørensen IJ; Hermann KG; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Johansen JS; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Hansen A; Ostergaard M
Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
